Structural characterization of forced degradation products of empagliflozin by high resolution mass spectrometry

A Predominant Oxidative Renal Metabolite of Empagliflozin in Male Mice Is Cytotoxic in Mouse Renal Tubular Cells but not Genotoxic

(2017) James D. Smith et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

LC–MS/MS Determination of Empagliflozin and Metformin

(2017) Bassam M. Ayoub et al.   JOURNAL OF CHROMATOGRAPHIC SCIENCE

LC–MS/MS and NMR characterization of forced degradation products of mirabegron

(2016) Swetha Parsha et al.   JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES

Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4acid hydrolysis

(2015) Prinesh N. Patel et al.   JOURNAL OF MASS SPECTROMETRY

Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor

(2014) André J. Scheen   CLINICAL PHARMACOKINETICS

Empagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus

(2014) Lesley J. Scott   DRUGS

The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review

(2014) Janet B. McGill   Diabetes Therapy

Regulatory Aspects in Development of Stability-Indicating Methods: A Review

(2010) Renu Sehrawat et al.   CHROMATOGRAPHIA